RNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?

F Fabbiano, J Corsi, E Gurrieri… - Journal of …, 2020 - Wiley Online Library
Extracellular vesicles (EVs) are heterogeneous membranous particles released from the
cells through different biogenetic and secretory mechanisms. We now conceive EVs as …

Inhibition of RNA-binding proteins with small molecules

P Wu - Nature Reviews Chemistry, 2020 - nature.com
Protein–RNA interactions have crucial roles in various cellular activities, which, when
dysregulated, can lead to a range of human diseases. The identification of small molecules …

The RNA-binding protein HuR in human cancer: a friend or foe?

X Wu, L Xu - Advanced drug delivery reviews, 2022 - Elsevier
The RNA-binding proteins (RBPs) are critical trans factors that associate with specific cis
elements present in mRNAs whose stability and translation are subject to regulation. The …

[HTML][HTML] RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer

M Mehta, R Raguraman, R Ramesh… - Advanced drug delivery …, 2022 - Elsevier
Traditionally majority of eukaryotic gene expression is influenced by transcriptional and post-
transcriptional events. Alterations in the expression of proteins that act post-transcriptionally …

HuR as a molecular target for cancer therapeutics and immune-related disorders

M Majumder, P Chakraborty, S Mohan… - Advanced drug delivery …, 2022 - Elsevier
The control of eukaryotic gene expression occurs at multiple levels, from transcription to
messenger RNA processing, transport, localization, turnover, and translation. RNA-binding …

[HTML][HTML] Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis

X Wu, G Gardashova, L Lan, S Han, C Zhong… - Communications …, 2020 - nature.com
Patients diagnosed with metastatic breast cancer have a dismal 5-year survival rate of only
24%. The RNA-binding protein Hu antigen R (HuR) is upregulated in breast cancer, and …

RNA-binding proteins in cancer drug discovery

JB Bertoldo, S Müller, S Hüttelmaier - Drug discovery today, 2023 - Elsevier
Highlights•RNA-binding proteins (RBPs) are essential for tumorigenesis, immune evasion,
invasion, migration and metastasis, hence promising drug targets in cancer therapy.•Small …

[HTML][HTML] HuR controls glutaminase RNA metabolism

D Adamoski, L M. dos Reis, ACP Mafra… - Nature …, 2024 - nature.com
Glutaminase (GLS) is directly related to cell growth and tumor progression, making it a target
for cancer treatment. The RNA-binding protein HuR (encoded by the ELAVL1 gene) …

Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge

X Chen, J Yu, B Zhong, J Lu, JJ Lu, S Li, Y Lu - Pharmacological Research, 2019 - Elsevier
Abstract Salvia miltiorrhiza Bunge (Danshen), a famous traditional Chinese herb, has been
used clinically for the treatment of various diseases for centuries. Document data showed …

[HTML][HTML] HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis

M Palomo-Irigoyen, E Pérez-Andrés… - The Journal of …, 2020 - Am Soc Clin Investig
Cancer cells can develop a strong addiction to discrete molecular regulators, which control
the aberrant gene expression programs that drive and maintain the cancer phenotype. Here …